Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Hesperidin Ameliorates TNF-${\alpha}$-Mediated Insulin Resistance in Differentiated 3T3-L1 Cells

  • Received : 2012.10.19
  • Accepted : 2012.11.24
  • Published : 2012.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Adipose inflammation is linked to the development of insulin resistance and type 2 diabetes. Hesperidin (HES) is a flavonoid with antioxidant, anti-inflammatory and anti-diabetic properties. However, whether HES improves inflammation-mediated insulin resistance in adipose tissues remains unclear. The purpose of this study was to investigate whether HES attenuates inflammation-mediated insulin resistance in adipose tissue. Herein, RAW 264.7 cells and differentiated 3T3-L1 adipocytes were pretreated with various concentrations of HES in complete media for 1 h and then cultured in the presence or absence of LPS or TNF-${\alpha}$. Our results demonstrated that HES remarkably inhibited LPS-induced production of IL-6, TNF-${\alpha}$, and NO by RAW 264.7 cells in a dose-dependent manner. Also, HES inhibited TNF-${\alpha}$-induced production of IL-6 and $PGE_2$ in differentiated 3T3-L1 cells, while upregulated TNF-${\alpha}$-suppressed expression of adiponectin and PPAR-${\gamma}$ mRNA. These findings suggest that HES may ameliorate inflammation-mediated insulin resistance in adipose tissue.

Keywords

References

  1. Ajuwon, K.M. and Spurlock M.E., Adiponectin inhibits LPS-induced NFkappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1220-1225 (2005). https://doi.org/10.1152/ajpregu.00397.2004
  2. Akiyama, S., Katsumata, S., Suzuki, K., Ishimi, Y., Wu, J., and Uehara, M., Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J. Clin. Biochem. Nutr. 46, 87-92 (2010).
  3. Akiyama, S., Katsumata, S., Suzuki, K., Nakaya, Y., Ishimi, Y., and Uehara, M., Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci. Biotechnol. Biochem. 73, 2779-2782 (2009). https://doi.org/10.1271/bbb.90576
  4. Bastard, J.P., Maachi, M., Lagathu, C., Kim, M.J., Caron, M., Vidal, H., Capeau, J., and Feve, B., Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17, 4-12 (2006).
  5. Berg, A.H. and Scherer, P.E., Adipose Tissue, Inflammation, and Cardiovascular Disease. Circulation Research 96, 939-949 (2005). https://doi.org/10.1161/01.RES.0000163635.62927.34
  6. Buechler, C., Wanninger, J., and Neumeier, M., Adiponectin, a key adipokine in obesity related liver diseases. World J. Gastroenterol. 17, 2801-2811 (2011).
  7. Dallaire, P., Bellmann, K., Laplante, M., Gelinas, S., Centeno-Baez, C., Penfornis, P., Peyot, M.L., Latour, M.G., Lamontagne, J., Trujillo, M.E., Scherer, P.E., Prentki, M., Deshaies, Y., and Marette, A., Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptorgamma agonism. Diabetes 57, 1999-2011 (2008). https://doi.org/10.2337/db08-0540
  8. De Taeye, B.M., Novitskaya, T., McGuinness, O.P., Gleaves, L., Medda, M., Covington, J.W., and Vaughan, D.E., Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am. J. Physiol. Endocrinol. Metab. 293, E713-725 (2007). https://doi.org/10.1152/ajpendo.00194.2007
  9. Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P., and Bahouth, S.W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273-2282 (2004). https://doi.org/10.1210/en.2003-1336
  10. Fontana, L., Eagon, J.C., Trujillo, M.E., Scherer, P.E., and Klein, S., Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabete, 56, 1010-1013 (2007). https://doi.org/10.2337/db06-1656
  11. Garg, A., Garg, S., Zaneveld, L.J., and Singla, A.K., Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother. Res. 15, 655-669 (2001). https://doi.org/10.1002/ptr.1074
  12. Han, D.I., Hwang, B.Y., Hwang, S.Y., Park, J.H., Son, K.H., Lee, S.H., Chang, S.Y., Kang, S.J., Ro, J.S., and Lee, K.S., Isolation and quantitative analysis of hesperidin from Aurantii Fructus. Kor. J. Pharmacogn. 32, 93-97 (2001).
  13. Henkel, J., Neuschafer-Rube, F., Pathe-Neuschafer-Rube, A., and Püschel, G. P., Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes. Hepatology 50, 781-790 (2009). https://doi.org/10.1002/hep.23064
  14. Hosch, S.E., Olefsky, J.M., and Kim, J.J., APPLied mechanics: uncovering how adiponectin modulates insulin action. Cell Metab. 4, 5-6 (2006). https://doi.org/10.1016/j.cmet.2006.06.003
  15. Hsieh, P.S., Jin, J.S., Chiang, C.F., Chan, P.C., Chen, C.H., and Shih, K.C., COX-2-mediated inflammation in fat is crucial for obesitylinked insulin resistance and fatty liver. Obesity (Silver Spring) 17, 1150-1157 (2009).
  16. Jain, M. and Parmar, H.S., Evaluation of antioxidative and antiinflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm. Res. 60, 483-491 (2011). https://doi.org/10.1007/s00011-010-0295-0
  17. Jung, U.J., Lee, M.K., Park, Y.B., Kang, M.A., and Choi, M.S., Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int. J. Biochem. Cell. Biol. 38, 1134-1145 (2006). https://doi.org/10.1016/j.biocel.2005.12.002
  18. Kim, H.J., Higashimori, T., Park, S.Y., Choi, H., Dong, J., Kim, Y.J., Noh, H.L., Cho, Y.R., Cline, G.., Kim, J.H., Bachmann, R.A., and Chen, J., Interleukin-6 and insulin resistance. Vitam. Horm. 80, 613-633 (2009).
  19. Klover, P.J., Clementi, A.H., and Mooney, R.A., Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146, 3417-3427 (2005). https://doi.org/10.1210/en.2004-1468
  20. Klover, P.J., Zimmers, T.A., Koniaris, L.G., and Mooney, R.A., Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52, 2784-2789 (2003). https://doi.org/10.2337/diabetes.52.11.2784
  21. Liu, T.T., Shih, K.C., Kao, C.C., Cheng, W.T., and Hsieh, P.S., Importance of cyclooxygenase 2-mediated low-grade inflammation in the development of fructose-induced insulin resistance in rats. Chin. J. Physiol. 52, 65-71 (2009).
  22. Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I., and Matsuzawa, Y., PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099 (2001). https://doi.org/10.2337/diabetes.50.9.2094
  23. Matsunaga, T., Shoji, A., Gu, N., Joo, E., Li, S., Adachi, T., Yamazaki, H., Yasuda, K., Kondoh, T., and Tsuda, K., ${\gamma}$-Tocotrienol attenuates TNF-${\alpha}$-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes. Mol. Med. Report 5, 905-909 (2012).
  24. Meshkani, R. and Adeli, K., Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin. Biochem. 42, 1331-1346 (2009). https://doi.org/10.1016/j.clinbiochem.2009.05.018
  25. Perreault, M. and Marette, A., Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7, 1138-43 (2001). https://doi.org/10.1038/nm1001-1138
  26. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., and Ridker, P.M., Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J. Am. Med. Assoc. 286, 327-334 (2001). https://doi.org/10.1001/jama.286.3.327
  27. Ricote, M., and Glass, C. K., PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta. 1771, 926-935 (2007). https://doi.org/10.1016/j.bbalip.2007.02.013
  28. Ruan, H., and Lodish, H.F., Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev. 14, 447-455 (2003). https://doi.org/10.1016/S1359-6101(03)00052-2
  29. Schultz, O., Oberhauser, F., Saech, J., Rubbert-Roth, A., Hahn, M., Krone, W., and Laudes, M., Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases. PLoS One 5, e14328-14334 (2010). https://doi.org/10.1371/journal.pone.0014328
  30. Senn, J.J., Klover, P.J., Nowak, I.A., and Mooney, R.A., Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391-3399 (2002). https://doi.org/10.2337/diabetes.51.12.3391
  31. Senn, J.J., Klover, P.J., Nowak, I.A., Zimmers, T.A., Koniaris, L.G., Furlanetto, R.W., and Mooney, R.A., Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278, 13740-13746 (2003). https://doi.org/10.1074/jbc.M210689200
  32. Sharma, A.M. and Staels, B., Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 92, 386-395 (2007).
  33. Sun, H., Zhang, Y., Gao, P., Li, Q., Sun, Y., Zhang, J., and Xu, C., Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells. Mol. Cell. Biochem. 347, 183-189 (2011). https://doi.org/10.1007/s11010-010-0627-y
  34. Staels, B., PPAR agonists and the metabolic syndrome. Therapie. 62, 319-326 (2007). https://doi.org/10.2515/therapie:2007051
  35. Vozarova, B., Weyer, C., Hanson, K., Tataranni, P.A., Bogardus, C., and Pratley, R.E., Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res. 9, 414-417 (2001). https://doi.org/10.1038/oby.2001.54
  36. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and Ferrante, Jr A.W., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
  37. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., and Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
  38. Yeh, C.C., Kao, S.J., Lin, C.C., Wang, S.D., Liu, C.J., and Kao, S.T., The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci. 80, 1821-1831 (2007). https://doi.org/10.1016/j.lfs.2007.01.052
  39. Zhang, D., Sun, M., Samols, D., and Kushner, I., STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem. 271, 9503-9509 (1996). https://doi.org/10.1074/jbc.271.16.9503